Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ubp1
|
ENSMUSG00000009741.8 | upstream binding protein 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_113969760_113969977 | Ubp1 | 643 | 0.578846 | -0.63 | 5.4e-08 | Click! |
chr9_113969212_113969700 | Ubp1 | 231 | 0.900775 | -0.61 | 3.0e-07 | Click! |
chr9_113933635_113933797 | Ubp1 | 2062 | 0.344531 | -0.60 | 4.5e-07 | Click! |
chr9_113941322_113941799 | Ubp1 | 9906 | 0.198478 | -0.58 | 1.3e-06 | Click! |
chr9_113931478_113932740 | Ubp1 | 455 | 0.841619 | -0.55 | 6.7e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_81737002_81738450 | 9.04 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
651 |
0.81 |
chr1_73961876_73963067 | 6.89 |
Tns1 |
tensin 1 |
572 |
0.8 |
chr17_26840029_26840609 | 6.65 |
Nkx2-5 |
NK2 homeobox 5 |
1246 |
0.32 |
chr2_180387025_180387876 | 6.51 |
B230312C02Rik |
RIKEN cDNA B230312C02 gene |
1565 |
0.24 |
chr14_34587287_34588669 | 6.28 |
Ldb3 |
LIM domain binding 3 |
503 |
0.69 |
chr14_54991806_54993467 | 6.13 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
1055 |
0.25 |
chr5_125386055_125387945 | 5.85 |
Ubc |
ubiquitin C |
2186 |
0.18 |
chrX_101449122_101450190 | 5.84 |
Itgb1bp2 |
integrin beta 1 binding protein 2 |
568 |
0.66 |
chr8_121118797_121121438 | 5.70 |
Foxc2 |
forkhead box C2 |
3946 |
0.14 |
chr16_38364563_38365451 | 5.49 |
Popdc2 |
popeye domain containing 2 |
2762 |
0.17 |
chr7_44474127_44475010 | 5.45 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
1030 |
0.25 |
chr1_172296846_172298307 | 5.36 |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
488 |
0.67 |
chr12_119945587_119946924 | 5.26 |
Tmem196 |
transmembrane protein 196 |
155 |
0.95 |
chr8_128362179_128363441 | 5.24 |
Nrp1 |
neuropilin 1 |
3413 |
0.27 |
chr16_13357876_13359918 | 5.16 |
Mrtfb |
myocardin related transcription factor B |
476 |
0.83 |
chr7_4520460_4522358 | 5.09 |
Tnni3 |
troponin I, cardiac 3 |
842 |
0.35 |
chr17_48431455_48432112 | 5.08 |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
835 |
0.47 |
chr1_65122655_65123419 | 5.06 |
D630023F18Rik |
RIKEN cDNA D630023F18 gene |
77 |
0.95 |
chr16_72027587_72029370 | 4.99 |
Gm49667 |
predicted gene, 49667 |
149434 |
0.04 |
chr5_122105936_122106110 | 4.99 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
2110 |
0.23 |
chr6_91795276_91796520 | 4.97 |
Grip2 |
glutamate receptor interacting protein 2 |
346 |
0.87 |
chr13_72629730_72632045 | 4.81 |
Irx2 |
Iroquois homeobox 2 |
1062 |
0.51 |
chr9_50752994_50754649 | 4.76 |
Cryab |
crystallin, alpha B |
574 |
0.54 |
chr14_54964935_54965983 | 4.69 |
Myh6 |
myosin, heavy polypeptide 6, cardiac muscle, alpha |
1115 |
0.21 |
chr3_138067510_138069146 | 4.65 |
Gm5105 |
predicted gene 5105 |
940 |
0.46 |
chr4_147986271_147987020 | 4.64 |
Nppb |
natriuretic peptide type B |
857 |
0.42 |
chr5_5264770_5266186 | 4.60 |
Cdk14 |
cyclin-dependent kinase 14 |
169 |
0.96 |
chr11_43834010_43835381 | 4.39 |
Adra1b |
adrenergic receptor, alpha 1b |
1637 |
0.47 |
chr8_12947702_12949640 | 4.33 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chr12_113141740_113143605 | 4.32 |
Crip2 |
cysteine rich protein 2 |
136 |
0.92 |
chr8_118285307_118286252 | 4.32 |
Cdh13 |
cadherin 13 |
1982 |
0.46 |
chr2_91119045_91119896 | 4.26 |
Mybpc3 |
myosin binding protein C, cardiac |
1326 |
0.3 |
chr3_138069501_138070764 | 4.23 |
1110002E22Rik |
RIKEN cDNA 1110002E22 gene |
1465 |
0.3 |
chr1_135799428_135800706 | 4.22 |
Tnni1 |
troponin I, skeletal, slow 1 |
234 |
0.9 |
chr14_32684554_32685266 | 4.02 |
3425401B19Rik |
RIKEN cDNA 3425401B19 gene |
362 |
0.71 |
chr11_65269494_65270784 | 4.00 |
Myocd |
myocardin |
150 |
0.96 |
chr1_166126774_166128045 | 4.00 |
Dusp27 |
dual specificity phosphatase 27 (putative) |
487 |
0.76 |
chr7_126248023_126249285 | 3.98 |
Sbk1 |
SH3-binding kinase 1 |
208 |
0.69 |
chr2_69670826_69672050 | 3.97 |
Klhl41 |
kelch-like 41 |
1318 |
0.37 |
chr2_138277835_138280637 | 3.96 |
Btbd3 |
BTB (POZ) domain containing 3 |
743 |
0.81 |
chr10_25199343_25200463 | 3.96 |
Akap7 |
A kinase (PRKA) anchor protein 7 |
255 |
0.93 |
chr10_33083500_33083959 | 3.94 |
Trdn |
triadin |
168 |
0.97 |
chr8_104101710_104103631 | 3.93 |
Cdh5 |
cadherin 5 |
1045 |
0.43 |
chr12_15813034_15813970 | 3.91 |
Trib2 |
tribbles pseudokinase 2 |
3283 |
0.19 |
chr5_148265188_148266164 | 3.89 |
Mtus2 |
microtubule associated tumor suppressor candidate 2 |
331 |
0.91 |
chr1_193369065_193370282 | 3.86 |
Camk1g |
calcium/calmodulin-dependent protein kinase I gamma |
552 |
0.7 |
chr12_100779025_100779814 | 3.83 |
Dglucy |
D-glutamate cyclase |
283 |
0.88 |
chr1_135818207_135820428 | 3.83 |
Lad1 |
ladinin |
719 |
0.58 |
chr7_139833633_139836105 | 3.82 |
Adgra1 |
adhesion G protein-coupled receptor A1 |
93 |
0.96 |
chr17_10310875_10311530 | 3.82 |
Qk |
quaking |
8159 |
0.24 |
chr10_78787171_78788340 | 3.82 |
Slc1a6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
7053 |
0.14 |
chr1_188006897_188007904 | 3.79 |
9330162B11Rik |
RIKEN cDNA 9330162B11 gene |
1590 |
0.45 |
chr9_56866808_56868850 | 3.77 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
2796 |
0.18 |
chr7_49247685_49248635 | 3.77 |
Nav2 |
neuron navigator 2 |
1315 |
0.51 |
chr11_57011668_57012922 | 3.77 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
339 |
0.94 |
chr2_181155937_181157234 | 3.77 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
429 |
0.73 |
chr9_50751156_50752468 | 3.76 |
Cryab |
crystallin, alpha B |
65 |
0.86 |
chr7_142474634_142476734 | 3.75 |
Lsp1 |
lymphocyte specific 1 |
690 |
0.52 |
chr1_83407298_83408547 | 3.74 |
Sphkap |
SPHK1 interactor, AKAP domain containing |
217 |
0.94 |
chr16_35157395_35159144 | 3.73 |
Adcy5 |
adenylate cyclase 5 |
3392 |
0.29 |
chr11_101892225_101894406 | 3.72 |
Meox1 |
mesenchyme homeobox 1 |
1059 |
0.4 |
chr19_6384347_6385874 | 3.71 |
Pygm |
muscle glycogen phosphorylase |
695 |
0.45 |
chr9_21196536_21198489 | 3.65 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
807 |
0.45 |
chr8_46208542_46209617 | 3.64 |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
1951 |
0.2 |
chr6_55451730_55453138 | 3.63 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
257 |
0.93 |
chr6_115984719_115988278 | 3.62 |
Plxnd1 |
plexin D1 |
8507 |
0.15 |
chr10_4709783_4710728 | 3.58 |
Esr1 |
estrogen receptor 1 (alpha) |
100 |
0.98 |
chr10_63886368_63887080 | 3.57 |
Gm10118 |
predicted gene 10118 |
40710 |
0.19 |
chr13_12105059_12105454 | 3.56 |
Ryr2 |
ryanodine receptor 2, cardiac |
1203 |
0.48 |
chr10_5287995_5289689 | 3.53 |
Gm23573 |
predicted gene, 23573 |
68331 |
0.12 |
chr2_107292125_107293014 | 3.49 |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
1174 |
0.64 |
chr3_84219870_84221146 | 3.47 |
Trim2 |
tripartite motif-containing 2 |
337 |
0.91 |
chr4_62699646_62700723 | 3.46 |
Rgs3 |
regulator of G-protein signaling 3 |
504 |
0.76 |
chr2_62046631_62048214 | 3.44 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
777 |
0.76 |
chr8_12926230_12928559 | 3.43 |
Mcf2l |
mcf.2 transforming sequence-like |
762 |
0.52 |
chr15_41819857_41820760 | 3.43 |
Oxr1 |
oxidation resistance 1 |
10624 |
0.21 |
chr10_38968014_38968667 | 3.42 |
Lama4 |
laminin, alpha 4 |
2668 |
0.33 |
chr6_17309182_17310034 | 3.41 |
Cav1 |
caveolin 1, caveolae protein |
1885 |
0.33 |
chr10_34299043_34301066 | 3.41 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr3_57293752_57294965 | 3.41 |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
194 |
0.95 |
chr6_148442590_148443383 | 3.40 |
Tmtc1 |
transmembrane and tetratricopeptide repeat containing 1 |
1351 |
0.46 |
chr2_14823792_14824714 | 3.39 |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
161 |
0.94 |
chr2_114048949_114049437 | 3.38 |
Actc1 |
actin, alpha, cardiac muscle 1 |
3694 |
0.19 |
chr17_70521708_70522843 | 3.38 |
Dlgap1 |
DLG associated protein 1 |
113 |
0.98 |
chr2_55436043_55436650 | 3.37 |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
376 |
0.9 |
chr18_37661708_37662765 | 3.36 |
Gm37118 |
predicted gene, 37118 |
396 |
0.39 |
chr17_24643558_24645911 | 3.35 |
Slc9a3r2 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 |
223 |
0.82 |
chr9_32343665_32344898 | 3.34 |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
1 |
0.97 |
chr6_83179353_83180686 | 3.33 |
Dctn1 |
dynactin 1 |
406 |
0.67 |
chr11_59138017_59138780 | 3.33 |
Obscn |
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
772 |
0.52 |
chr13_105249326_105250833 | 3.32 |
Rnf180 |
ring finger protein 180 |
20960 |
0.22 |
chr6_148046801_148048056 | 3.32 |
Far2 |
fatty acyl CoA reductase 2 |
12 |
0.57 |
chr6_91806804_91807812 | 3.30 |
Grip2 |
glutamate receptor interacting protein 2 |
10 |
0.98 |
chr10_63457257_63458786 | 3.29 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
511 |
0.78 |
chr10_76724744_76726005 | 3.29 |
Col6a1 |
collagen, type VI, alpha 1 |
794 |
0.59 |
chr15_77021062_77022444 | 3.27 |
Mb |
myoglobin |
210 |
0.89 |
chr3_102088246_102088855 | 3.23 |
Casq2 |
calsequestrin 2 |
1911 |
0.26 |
chr8_94266327_94267391 | 3.22 |
Nup93 |
nucleoporin 93 |
12 |
0.96 |
chr6_92478725_92480195 | 3.21 |
Prickle2 |
prickle planar cell polarity protein 2 |
1932 |
0.44 |
chr9_5345433_5346237 | 3.20 |
Casp12 |
caspase 12 |
331 |
0.91 |
chr14_32683140_32683919 | 3.19 |
3425401B19Rik |
RIKEN cDNA 3425401B19 gene |
1743 |
0.31 |
chr10_79806462_79808470 | 3.18 |
Palm |
paralemmin |
785 |
0.35 |
chr6_126534159_126535726 | 3.18 |
Kcna5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
470 |
0.81 |
chr1_188002104_188003122 | 3.17 |
Esrrg |
estrogen-related receptor gamma |
4745 |
0.26 |
chr6_135362982_135365483 | 3.15 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr10_119818950_119820160 | 3.15 |
Grip1 |
glutamate receptor interacting protein 1 |
30 |
0.98 |
chr12_85435524_85436431 | 3.15 |
Gm40477 |
predicted gene, 40477 |
104 |
0.96 |
chr10_117045396_117046504 | 3.15 |
Lrrc10 |
leucine rich repeat containing 10 |
609 |
0.61 |
chr13_73260273_73261531 | 3.14 |
Irx4 |
Iroquois homeobox 4 |
405 |
0.82 |
chr1_119419067_119420042 | 3.13 |
Inhbb |
inhibin beta-B |
2694 |
0.27 |
chr2_107291496_107291737 | 3.12 |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
221 |
0.96 |
chr11_47377104_47378325 | 3.10 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
1808 |
0.52 |
chr18_60963604_60964955 | 3.09 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
679 |
0.59 |
chr5_103210548_103211780 | 3.08 |
Mapk10 |
mitogen-activated protein kinase 10 |
109 |
0.98 |
chr6_56361313_56362588 | 3.07 |
Pde1c |
phosphodiesterase 1C |
95 |
0.98 |
chr6_64799057_64799968 | 3.06 |
Atoh1 |
atonal bHLH transcription factor 1 |
70387 |
0.11 |
chr10_25198245_25199220 | 3.06 |
Akap7 |
A kinase (PRKA) anchor protein 7 |
1426 |
0.46 |
chr15_85677376_85679232 | 3.05 |
Lncppara |
long noncoding RNA near Ppara |
24688 |
0.12 |
chr7_44443183_44443767 | 3.05 |
Lrrc4b |
leucine rich repeat containing 4B |
738 |
0.4 |
chr8_8655111_8656501 | 3.05 |
Efnb2 |
ephrin B2 |
5433 |
0.1 |
chr1_146494200_146495557 | 3.05 |
Gm29514 |
predicted gene 29514 |
73 |
0.56 |
chr10_110921543_110922443 | 3.03 |
Csrp2 |
cysteine and glycine-rich protein 2 |
1788 |
0.28 |
chr10_128933398_128934602 | 3.03 |
Itga7 |
integrin alpha 7 |
56 |
0.94 |
chr2_152931122_152933148 | 3.01 |
Foxs1 |
forkhead box S1 |
1073 |
0.38 |
chr13_113662555_113662899 | 3.01 |
Hspb3 |
heat shock protein 3 |
949 |
0.53 |
chr8_45507516_45508498 | 2.98 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
89 |
0.97 |
chr12_103336858_103338251 | 2.95 |
Gm15523 |
predicted gene 15523 |
648 |
0.43 |
chr14_103840123_103841623 | 2.94 |
Ednrb |
endothelin receptor type B |
2822 |
0.37 |
chr4_127311434_127313205 | 2.94 |
Gja4 |
gap junction protein, alpha 4 |
1720 |
0.26 |
chr2_105370584_105371218 | 2.93 |
Rcn1 |
reticulocalbin 1 |
24447 |
0.22 |
chr9_76322366_76323081 | 2.91 |
Hcrtr2 |
hypocretin (orexin) receptor 2 |
599 |
0.76 |
chr18_47367607_47368430 | 2.91 |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
250 |
0.93 |
chr14_119857212_119858081 | 2.91 |
4930404K13Rik |
RIKEN cDNA 4930404K13 gene |
58668 |
0.13 |
chr4_5724213_5725550 | 2.91 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr1_118481967_118482873 | 2.91 |
Clasp1 |
CLIP associating protein 1 |
381 |
0.8 |
chr13_58809397_58810364 | 2.90 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
1189 |
0.34 |
chr14_54985534_54985950 | 2.90 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
1676 |
0.14 |
chr11_3330811_3331731 | 2.90 |
Gm12592 |
predicted gene 12592 |
93 |
0.84 |
chr6_136873814_136874977 | 2.90 |
Mgp |
matrix Gla protein |
1386 |
0.26 |
chr18_23415065_23416860 | 2.90 |
Dtna |
dystrobrevin alpha |
452 |
0.9 |
chr9_52678302_52679671 | 2.89 |
AI593442 |
expressed sequence AI593442 |
443 |
0.69 |
chr5_122107449_122108399 | 2.89 |
Ccdc63 |
coiled-coil domain containing 63 |
3189 |
0.18 |
chr3_96181539_96182795 | 2.89 |
Sv2a |
synaptic vesicle glycoprotein 2 a |
1016 |
0.22 |
chr5_117240468_117241490 | 2.88 |
Taok3 |
TAO kinase 3 |
519 |
0.72 |
chr17_26838158_26839992 | 2.86 |
Nkx2-5 |
NK2 homeobox 5 |
2490 |
0.17 |
chr11_5802324_5803834 | 2.86 |
Pgam2 |
phosphoglycerate mutase 2 |
654 |
0.56 |
chr3_53043747_53045351 | 2.85 |
Gm42901 |
predicted gene 42901 |
2794 |
0.16 |
chr5_77092587_77093501 | 2.85 |
Hopxos |
HOP homeobox, opposite strand |
1488 |
0.28 |
chr12_95691954_95693678 | 2.85 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
590 |
0.73 |
chr4_82499658_82501360 | 2.84 |
Nfib |
nuclear factor I/B |
1193 |
0.5 |
chr12_34527603_34529023 | 2.84 |
Hdac9 |
histone deacetylase 9 |
9 |
0.99 |
chr11_118201461_118202720 | 2.83 |
Gm11737 |
predicted gene 11737 |
3089 |
0.2 |
chr1_160350716_160351791 | 2.83 |
Rabgap1l |
RAB GTPase activating protein 1-like |
318 |
0.88 |
chr7_67848611_67849816 | 2.83 |
Gm39027 |
predicted gene, 39027 |
419 |
0.8 |
chr1_153307880_153309190 | 2.83 |
Gm8818 |
predicted pseudogene 8818 |
3103 |
0.23 |
chr2_156774819_156776414 | 2.83 |
Myl9 |
myosin, light polypeptide 9, regulatory |
159 |
0.92 |
chrX_137569718_137571626 | 2.83 |
Il1rapl2 |
interleukin 1 receptor accessory protein-like 2 |
64 |
0.98 |
chr19_53680794_53681963 | 2.82 |
Rbm20 |
RNA binding motif protein 20 |
4072 |
0.23 |
chr14_101886945_101887764 | 2.81 |
Lmo7 |
LIM domain only 7 |
3235 |
0.35 |
chr8_45658542_45659771 | 2.79 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
352 |
0.89 |
chr7_3301817_3302985 | 2.79 |
Prkcg |
protein kinase C, gamma |
1121 |
0.28 |
chr1_187999916_188000681 | 2.79 |
Esrrg |
estrogen-related receptor gamma |
2430 |
0.35 |
chr3_79887847_79889192 | 2.79 |
Gm36569 |
predicted gene, 36569 |
1713 |
0.31 |
chr15_21110687_21111815 | 2.78 |
Cdh12 |
cadherin 12 |
201 |
0.94 |
chr1_51291546_51292409 | 2.78 |
Cavin2 |
caveolae associated 2 |
2851 |
0.27 |
chr14_63247276_63249044 | 2.78 |
Gata4 |
GATA binding protein 4 |
2889 |
0.24 |
chr8_22757309_22759411 | 2.77 |
Plat |
plasminogen activator, tissue |
565 |
0.71 |
chr2_35557994_35559313 | 2.76 |
Gm13446 |
predicted gene 13446 |
49 |
0.85 |
chr6_36808560_36810410 | 2.76 |
Ptn |
pleiotrophin |
694 |
0.79 |
chr5_9724633_9726223 | 2.74 |
Grm3 |
glutamate receptor, metabotropic 3 |
258 |
0.93 |
chr11_61453075_61454398 | 2.74 |
Rnf112 |
ring finger protein 112 |
183 |
0.92 |
chr3_102469696_102470976 | 2.73 |
Ngf |
nerve growth factor |
408 |
0.85 |
chr5_122093323_122094551 | 2.73 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
7014 |
0.14 |
chr14_34585878_34586349 | 2.73 |
Ldb3 |
LIM domain binding 3 |
2368 |
0.19 |
chr6_29434692_29436459 | 2.72 |
Flnc |
filamin C, gamma |
2299 |
0.16 |
chr2_180388160_180389480 | 2.72 |
Mir1a-1 |
microRNA 1a-1 |
228 |
0.89 |
chr18_38928285_38929463 | 2.70 |
Fgf1 |
fibroblast growth factor 1 |
283 |
0.92 |
chr14_25610327_25611867 | 2.69 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
3259 |
0.25 |
chr13_12334755_12335919 | 2.69 |
Actn2 |
actinin alpha 2 |
5387 |
0.19 |
chr10_8761475_8762950 | 2.68 |
Sash1 |
SAM and SH3 domain containing 1 |
262 |
0.93 |
chr19_34253411_34255499 | 2.67 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
225 |
0.92 |
chr10_81328518_81330009 | 2.66 |
Tbxa2r |
thromboxane A2 receptor |
532 |
0.47 |
chr1_134232926_134233818 | 2.65 |
Adora1 |
adenosine A1 receptor |
1206 |
0.39 |
chr13_63242151_63243167 | 2.65 |
Gm47586 |
predicted gene, 47586 |
1562 |
0.22 |
chr17_62784126_62785184 | 2.65 |
Efna5 |
ephrin A5 |
96489 |
0.09 |
chr5_72503313_72504626 | 2.64 |
Corin |
corin, serine peptidase |
239 |
0.89 |
chr8_120971907_120972979 | 2.64 |
Gm28324 |
predicted gene 28324 |
30484 |
0.16 |
chr8_11314471_11315722 | 2.64 |
Col4a1 |
collagen, type IV, alpha 1 |
2270 |
0.23 |
chr13_18948406_18949248 | 2.64 |
Amph |
amphiphysin |
429 |
0.8 |
chr2_67567206_67567506 | 2.63 |
B3galt1 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
1485 |
0.44 |
chr11_90030594_90032253 | 2.63 |
Tmem100 |
transmembrane protein 100 |
1075 |
0.58 |
chr14_123201613_123202658 | 2.63 |
AA536875 |
expressed sequence AA536875 |
32841 |
0.19 |
chr2_96317494_96318819 | 2.63 |
Lrrc4c |
leucine rich repeat containing 4C |
13 |
0.99 |
chr10_76583951_76585206 | 2.62 |
Ftcd |
formiminotransferase cyclodeaminase |
2555 |
0.18 |
chr10_64084748_64085397 | 2.62 |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
5175 |
0.34 |
chr1_62704948_62705819 | 2.62 |
Nrp2 |
neuropilin 2 |
1681 |
0.35 |
chr4_102760289_102761654 | 2.62 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
446 |
0.87 |
chr13_46926552_46927282 | 2.61 |
Kif13a |
kinesin family member 13A |
2800 |
0.19 |
chr3_115712293_115713025 | 2.61 |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
2413 |
0.28 |
chr11_57836623_57837461 | 2.61 |
Hand1 |
heart and neural crest derivatives expressed 1 |
4224 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 25.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
4.3 | 12.8 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
4.0 | 7.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
3.7 | 11.2 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
3.3 | 13.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
3.3 | 9.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.2 | 13.0 | GO:0060486 | Clara cell differentiation(GO:0060486) |
3.1 | 3.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
3.1 | 9.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.9 | 5.7 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.8 | 8.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.7 | 8.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
2.6 | 7.8 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
2.6 | 13.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
2.6 | 12.9 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
2.5 | 7.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.5 | 7.4 | GO:1903375 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
2.5 | 12.4 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
2.5 | 7.4 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.4 | 7.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.4 | 9.6 | GO:0030035 | microspike assembly(GO:0030035) |
2.3 | 7.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.3 | 18.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.3 | 11.6 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
2.3 | 20.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
2.3 | 6.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
2.3 | 11.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
2.2 | 8.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.1 | 4.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
2.1 | 6.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
2.1 | 6.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.1 | 2.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.1 | 6.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
2.1 | 4.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
2.0 | 4.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.0 | 6.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
2.0 | 5.9 | GO:0007525 | somatic muscle development(GO:0007525) |
2.0 | 7.9 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.9 | 1.9 | GO:0051795 | positive regulation of catagen(GO:0051795) |
1.9 | 5.6 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.9 | 5.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.8 | 5.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.8 | 3.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.8 | 5.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.8 | 3.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.8 | 5.5 | GO:0021564 | vagus nerve development(GO:0021564) |
1.8 | 3.6 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.8 | 12.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.8 | 10.6 | GO:1990000 | amyloid fibril formation(GO:1990000) |
1.8 | 1.8 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
1.7 | 8.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.7 | 8.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.6 | 4.9 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
1.6 | 1.6 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
1.6 | 4.9 | GO:0030421 | defecation(GO:0030421) |
1.6 | 6.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
1.6 | 3.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.6 | 4.7 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.6 | 10.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.6 | 20.3 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
1.5 | 6.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.5 | 1.5 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
1.5 | 1.5 | GO:0003161 | cardiac conduction system development(GO:0003161) |
1.5 | 6.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.5 | 4.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.5 | 7.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.5 | 3.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
1.5 | 1.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.5 | 2.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.5 | 10.3 | GO:0097264 | self proteolysis(GO:0097264) |
1.4 | 7.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.4 | 5.7 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.4 | 8.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.4 | 12.7 | GO:0071625 | vocalization behavior(GO:0071625) |
1.4 | 12.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.4 | 4.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.4 | 8.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.4 | 5.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.3 | 8.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.3 | 6.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.3 | 10.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.3 | 2.6 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.3 | 5.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.3 | 3.9 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.3 | 2.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.3 | 6.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.3 | 3.8 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
1.3 | 3.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.3 | 3.8 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
1.3 | 3.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.3 | 2.5 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.3 | 3.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.2 | 2.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.2 | 1.2 | GO:0071436 | sodium ion export(GO:0071436) |
1.2 | 5.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.2 | 2.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.2 | 3.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.2 | 3.7 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.2 | 3.7 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.2 | 1.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.2 | 3.6 | GO:0060513 | prostatic bud formation(GO:0060513) |
1.2 | 1.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.2 | 1.2 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
1.2 | 3.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.2 | 7.1 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
1.2 | 5.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.2 | 4.7 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
1.2 | 3.5 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.2 | 1.2 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.2 | 3.5 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
1.2 | 4.6 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.1 | 3.4 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.1 | 1.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.1 | 7.9 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
1.1 | 2.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.1 | 1.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.1 | 4.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.1 | 3.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.1 | 3.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.1 | 1.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.1 | 9.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
1.1 | 10.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.1 | 3.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.1 | 8.6 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
1.1 | 4.3 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.1 | 2.1 | GO:0001757 | somite specification(GO:0001757) |
1.1 | 3.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.1 | 3.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.0 | 5.2 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
1.0 | 4.2 | GO:0061743 | motor learning(GO:0061743) |
1.0 | 7.3 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
1.0 | 2.1 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.0 | 3.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.0 | 3.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.0 | 6.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.0 | 15.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.0 | 2.0 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
1.0 | 3.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.0 | 1.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
1.0 | 1.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.0 | 12.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.0 | 5.0 | GO:0070842 | aggresome assembly(GO:0070842) |
1.0 | 2.0 | GO:0098901 | regulation of cardiac muscle cell action potential(GO:0098901) |
1.0 | 3.9 | GO:0030091 | protein repair(GO:0030091) |
1.0 | 2.0 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.0 | 1.9 | GO:0086001 | cardiac muscle cell action potential(GO:0086001) |
1.0 | 4.9 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.0 | 4.9 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.0 | 3.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.0 | 1.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.0 | 9.6 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.0 | 2.9 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.0 | 1.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.0 | 3.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.9 | 8.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.9 | 7.6 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.9 | 12.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.9 | 0.9 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.9 | 5.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.9 | 0.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.9 | 1.9 | GO:0008306 | associative learning(GO:0008306) |
0.9 | 7.4 | GO:0060013 | righting reflex(GO:0060013) |
0.9 | 0.9 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.9 | 2.8 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.9 | 14.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.9 | 2.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.9 | 7.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.9 | 2.7 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.9 | 0.9 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.9 | 2.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.9 | 6.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.9 | 3.6 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.9 | 3.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.9 | 0.9 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.9 | 2.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.9 | 7.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.9 | 1.8 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.9 | 4.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.9 | 9.6 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.9 | 1.7 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.9 | 6.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.9 | 3.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.9 | 6.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.9 | 0.9 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.9 | 3.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.9 | 3.4 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.9 | 0.9 | GO:0051794 | regulation of catagen(GO:0051794) |
0.8 | 2.5 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.8 | 2.5 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.8 | 2.5 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
0.8 | 3.4 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.8 | 2.5 | GO:0007494 | midgut development(GO:0007494) |
0.8 | 0.8 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.8 | 4.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.8 | 0.8 | GO:0048143 | astrocyte activation(GO:0048143) |
0.8 | 0.8 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.8 | 0.8 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.8 | 2.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 3.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.8 | 0.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.8 | 0.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.8 | 1.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.8 | 0.8 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.8 | 0.8 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.8 | 2.4 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.8 | 1.6 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.8 | 1.6 | GO:0021586 | pons maturation(GO:0021586) |
0.8 | 0.8 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.8 | 0.8 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.8 | 2.4 | GO:0060437 | lung growth(GO:0060437) |
0.8 | 2.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.8 | 0.8 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.8 | 1.6 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.8 | 3.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.8 | 2.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.8 | 14.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.8 | 37.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.8 | 2.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.8 | 1.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.8 | 1.5 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.8 | 2.3 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.8 | 1.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.8 | 0.8 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.8 | 2.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.8 | 3.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.8 | 0.8 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.8 | 11.4 | GO:0001964 | startle response(GO:0001964) |
0.8 | 2.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.8 | 54.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.8 | 3.8 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.7 | 0.7 | GO:0010986 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
0.7 | 2.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.7 | 2.9 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.7 | 0.7 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.7 | 2.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 0.7 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.7 | 16.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.7 | 1.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.7 | 2.1 | GO:0048840 | otolith development(GO:0048840) |
0.7 | 0.7 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.7 | 0.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.7 | 0.7 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.7 | 1.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.7 | 0.7 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.7 | 1.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.7 | 2.1 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.7 | 3.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.7 | 2.7 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.7 | 5.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.7 | 3.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.7 | 0.7 | GO:0060174 | limb bud formation(GO:0060174) |
0.7 | 1.3 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.7 | 1.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.7 | 1.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.7 | 2.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.7 | 0.7 | GO:2000848 | positive regulation of cortisol secretion(GO:0051464) positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of glucocorticoid secretion(GO:2000851) |
0.7 | 7.9 | GO:0060384 | innervation(GO:0060384) |
0.7 | 0.7 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.7 | 13.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.7 | 2.6 | GO:0032347 | negative regulation of aldosterone metabolic process(GO:0032345) regulation of aldosterone biosynthetic process(GO:0032347) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.7 | 0.7 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.6 | 1.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.6 | 9.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.6 | 0.6 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.6 | 1.9 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.6 | 0.6 | GO:0090032 | negative regulation of hormone biosynthetic process(GO:0032353) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.6 | 1.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.6 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 1.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.6 | 3.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.6 | 1.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.6 | 0.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 3.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.6 | 2.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.6 | 1.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 4.8 | GO:0015824 | proline transport(GO:0015824) |
0.6 | 1.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.6 | 1.8 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.6 | 1.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.6 | 4.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 1.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.6 | 1.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.6 | 5.8 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.6 | 1.2 | GO:0032439 | endosome localization(GO:0032439) |
0.6 | 1.7 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.6 | 1.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.6 | 1.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.6 | 0.6 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.6 | 2.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.6 | 1.1 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.6 | 0.6 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.6 | 1.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.6 | 1.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.6 | 5.1 | GO:0030239 | myofibril assembly(GO:0030239) |
0.6 | 0.6 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.6 | 6.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.6 | 1.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 2.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 2.2 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.6 | 1.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.6 | 3.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.6 | 1.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.6 | 5.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.6 | 1.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.6 | 2.8 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.5 | 0.5 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
0.5 | 0.5 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.5 | 1.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.5 | 1.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 1.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.5 | 2.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.5 | 2.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.5 | 0.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.5 | 1.6 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.5 | 0.5 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.5 | 1.6 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.5 | 1.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.5 | 2.7 | GO:0031000 | response to caffeine(GO:0031000) |
0.5 | 1.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.5 | 0.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.5 | 0.5 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.5 | 2.6 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.5 | 1.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.5 | 1.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.5 | 2.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.5 | 0.5 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.5 | 2.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 2.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.5 | 1.0 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.5 | 2.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 1.6 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.5 | 5.2 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.5 | 1.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.5 | 2.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.5 | 5.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 0.5 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.5 | 1.0 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.5 | 1.0 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.5 | 1.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.5 | 0.5 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.5 | 1.0 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.5 | 1.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 2.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 0.5 | GO:0060157 | urinary bladder development(GO:0060157) |
0.5 | 3.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.5 | 0.5 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.5 | 1.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.5 | 0.5 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.5 | 1.0 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.5 | 1.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 2.5 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.5 | 1.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.5 | 0.5 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.5 | 1.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 6.0 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.5 | 2.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.5 | 3.0 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.5 | 0.5 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
0.5 | 1.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 5.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.5 | 3.9 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.5 | 0.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.5 | 1.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.5 | 1.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.5 | 0.5 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.5 | 1.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 1.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 2.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 0.5 | GO:0060137 | parturition(GO:0007567) maternal process involved in parturition(GO:0060137) |
0.5 | 0.5 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.5 | 1.0 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.5 | 0.9 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 6.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.5 | 1.4 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.5 | 4.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.5 | 6.1 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.5 | 1.4 | GO:0014028 | notochord formation(GO:0014028) |
0.5 | 1.4 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.5 | 0.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.5 | 0.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.5 | 4.2 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.5 | 0.5 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.5 | 1.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.5 | 3.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.5 | 1.8 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.5 | 1.8 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.5 | 0.5 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.5 | 1.8 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.5 | 1.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.5 | 2.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.5 | 1.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.5 | 6.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 0.9 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.5 | 1.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.5 | 0.5 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.4 | 0.4 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 0.4 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.4 | 1.8 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.4 | 0.4 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.4 | 0.4 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.4 | 1.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.4 | 1.3 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.4 | 2.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 0.4 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 | 2.2 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.4 | 1.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 0.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.4 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.4 | 1.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 1.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.4 | 0.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 1.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.4 | 0.4 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.4 | 1.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.4 | 1.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.4 | 2.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.4 | 0.4 | GO:0060290 | transdifferentiation(GO:0060290) |
0.4 | 1.3 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.4 | 1.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 0.9 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.4 | 0.9 | GO:1902475 | L-glutamate transmembrane transport(GO:0089711) L-alpha-amino acid transmembrane transport(GO:1902475) |
0.4 | 2.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 3.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.4 | 1.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 0.8 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.4 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.4 | 0.4 | GO:1905209 | positive regulation of cardiocyte differentiation(GO:1905209) |
0.4 | 0.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.4 | 0.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.4 | 1.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 1.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 3.3 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.4 | 0.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 0.8 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.4 | 0.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 1.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 1.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.4 | 2.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.4 | 2.9 | GO:0032098 | regulation of appetite(GO:0032098) |
0.4 | 1.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.4 | 1.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 2.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.4 | 1.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.4 | 2.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 0.8 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.4 | 3.6 | GO:0030325 | adrenal gland development(GO:0030325) |
0.4 | 1.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 1.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 2.8 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.4 | 2.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.4 | 1.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 2.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.4 | 0.8 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 1.2 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 0.4 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 0.8 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 2.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 3.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 1.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 1.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 0.8 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.4 | 3.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.4 | 1.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 0.4 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.4 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.4 | 1.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.4 | 4.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.4 | 0.8 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.4 | 2.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.4 | 0.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 1.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 0.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 1.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.4 | 0.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.4 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 5.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.4 | 1.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.4 | 1.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.4 | 0.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.4 | 0.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 3.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 1.1 | GO:0060004 | reflex(GO:0060004) |
0.4 | 6.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 1.1 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) |
0.4 | 5.5 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.4 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.4 | 1.5 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.4 | 4.0 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.4 | 8.7 | GO:0008542 | visual learning(GO:0008542) |
0.4 | 1.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 0.4 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.4 | 0.7 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.4 | 1.4 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.4 | 0.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.4 | 1.4 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.4 | 0.4 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.4 | 1.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.4 | 1.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.4 | 3.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 0.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 6.3 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.3 | 1.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 1.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 1.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 1.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 20.8 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.3 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 0.7 | GO:0060618 | nipple development(GO:0060618) |
0.3 | 1.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 1.0 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.7 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 0.7 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 0.7 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 0.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 4.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.3 | 0.3 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.3 | 2.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 1.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 0.7 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 1.6 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.3 | 1.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 0.7 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 1.6 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.3 | 0.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 2.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.3 | 4.6 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.3 | 1.6 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.3 | 1.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.3 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.3 | 0.6 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.3 | 0.6 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.3 | 1.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 0.3 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.3 | 0.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.3 | 0.6 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 1.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 0.6 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.3 | 0.6 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.3 | 0.6 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 1.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 0.3 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.3 | 12.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 0.9 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 0.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 6.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.3 | 0.9 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 0.6 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.3 | 1.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 0.3 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 0.6 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.3 | 1.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.3 | 0.3 | GO:1903897 | regulation of PERK-mediated unfolded protein response(GO:1903897) |
0.3 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 2.6 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 1.5 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.3 | 0.6 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 3.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 0.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 0.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 1.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 2.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 0.9 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 0.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.6 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.3 | 0.6 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.3 | 2.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 0.6 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.3 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 0.6 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.3 | 0.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 1.7 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 0.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 2.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.6 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 1.4 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.3 | 1.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.3 | 2.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 0.8 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.3 | 1.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 0.6 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.3 | 1.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.3 | 1.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 0.3 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.3 | 0.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 0.5 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.3 | 1.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 0.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 0.8 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 1.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 1.1 | GO:0060180 | female mating behavior(GO:0060180) |
0.3 | 0.8 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 0.5 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 4.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.3 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 0.8 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.3 | 0.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 1.8 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 2.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.3 | 1.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.3 | 0.3 | GO:0043084 | penile erection(GO:0043084) |
0.3 | 0.3 | GO:0042220 | response to cocaine(GO:0042220) |
0.3 | 0.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 0.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.3 | 0.5 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.3 | 0.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 2.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 7.6 | GO:0050905 | neuromuscular process(GO:0050905) |
0.3 | 0.3 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.3 | 6.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 1.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 1.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 1.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 1.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 0.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.7 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.2 | 0.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 0.2 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.2 | 4.6 | GO:0003407 | neural retina development(GO:0003407) |
0.2 | 0.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.2 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 5.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.5 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 1.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.7 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.2 | 0.4 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 1.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 1.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.9 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 3.9 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.2 | 0.4 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 0.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.6 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.2 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.8 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 1.6 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 1.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.2 | 0.8 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.2 | 0.6 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.2 | GO:1900274 | regulation of phospholipase C activity(GO:1900274) |
0.2 | 0.4 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 0.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.2 | 2.7 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 0.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 0.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.4 | GO:0060594 | mammary gland specification(GO:0060594) |
0.2 | 2.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 1.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.7 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.2 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 3.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 1.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.4 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.2 | 0.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 3.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.2 | 0.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 0.4 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.2 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.2 | 0.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.2 | 1.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 3.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 0.2 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.2 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.3 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 1.0 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.2 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.3 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 1.0 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.7 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.2 | 1.2 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 1.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.7 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.3 | GO:0043301 | negative regulation of leukocyte degranulation(GO:0043301) |
0.2 | 0.8 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.2 | 0.3 | GO:0035637 | multicellular organismal signaling(GO:0035637) |
0.2 | 1.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 1.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.2 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.2 | 1.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 1.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.3 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.2 | 1.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.3 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.2 | 0.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.5 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 0.5 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 0.3 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 0.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.2 | 0.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 1.2 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.2 | 3.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 3.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.2 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.3 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.3 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.1 | 1.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.6 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 1.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.9 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 2.2 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 1.9 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 1.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.1 | 0.6 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.4 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 1.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.4 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.1 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 1.4 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.5 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.6 | GO:0060420 | regulation of heart growth(GO:0060420) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
0.1 | 0.2 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 1.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 1.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.5 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.6 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.3 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.5 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 1.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 1.4 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 0.3 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.2 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 0.3 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 4.8 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.5 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.2 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 1.5 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.1 | 1.4 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.1 | 1.0 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 4.2 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.2 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 1.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.4 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.6 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.3 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.2 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.1 | 0.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.2 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 0.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 1.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.3 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 1.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.3 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.1 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 4.6 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.1 | 0.1 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 5.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.8 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.1 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.5 | GO:0042551 | neuron maturation(GO:0042551) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.3 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 0.3 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.2 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0051284 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) |
0.1 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 2.1 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 2.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 2.8 | GO:0006936 | muscle contraction(GO:0006936) |
0.1 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.4 | GO:0030817 | regulation of cAMP biosynthetic process(GO:0030817) |
0.1 | 1.2 | GO:0055001 | muscle cell development(GO:0055001) |
0.1 | 0.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.1 | GO:0036257 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) late endosomal microautophagy(GO:0061738) |
0.1 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:0015872 | dopamine transport(GO:0015872) |
0.1 | 0.1 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.1 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 1.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.6 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.1 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.1 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.1 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 0.1 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.1 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.0 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.0 | 0.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.0 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 1.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.0 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
0.0 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 2.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.4 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.7 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.2 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.1 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.0 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.0 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.7 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 1.3 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 3.9 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.0 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.1 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.0 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.8 | 8.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
2.7 | 18.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.4 | 11.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.4 | 14.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
2.3 | 7.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.2 | 17.7 | GO:0005861 | troponin complex(GO:0005861) |
2.2 | 6.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.2 | 12.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.0 | 6.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.8 | 5.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.7 | 5.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.7 | 5.1 | GO:0043198 | dendritic shaft(GO:0043198) |
1.7 | 8.4 | GO:0031430 | M band(GO:0031430) |
1.6 | 18.0 | GO:0043194 | axon initial segment(GO:0043194) |
1.6 | 4.8 | GO:0072534 | perineuronal net(GO:0072534) |
1.6 | 14.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.4 | 4.3 | GO:0097443 | sorting endosome(GO:0097443) |
1.4 | 2.8 | GO:0044393 | microspike(GO:0044393) |
1.4 | 5.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.4 | 23.7 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
1.3 | 1.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.2 | 5.0 | GO:0044308 | axonal spine(GO:0044308) |
1.2 | 7.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.2 | 13.1 | GO:0043034 | costamere(GO:0043034) |
1.2 | 14.2 | GO:0005916 | fascia adherens(GO:0005916) |
1.2 | 9.4 | GO:0043083 | synaptic cleft(GO:0043083) |
1.1 | 16.1 | GO:0030673 | axolemma(GO:0030673) |
1.1 | 44.7 | GO:0030315 | T-tubule(GO:0030315) |
1.1 | 6.6 | GO:0005915 | zonula adherens(GO:0005915) |
1.1 | 3.2 | GO:0097441 | basilar dendrite(GO:0097441) |
1.1 | 17.9 | GO:0005614 | interstitial matrix(GO:0005614) |
1.0 | 3.1 | GO:0043511 | inhibin complex(GO:0043511) |
1.0 | 18.7 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.0 | 17.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.0 | 3.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.0 | 4.0 | GO:0030478 | actin cap(GO:0030478) |
1.0 | 6.0 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.0 | 3.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.9 | 7.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.9 | 2.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.9 | 0.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.9 | 64.0 | GO:0031674 | I band(GO:0031674) |
0.9 | 3.6 | GO:0016342 | catenin complex(GO:0016342) |
0.9 | 4.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.9 | 3.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 0.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.8 | 5.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.8 | 2.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.8 | 8.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.8 | 2.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.8 | 11.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.8 | 2.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.8 | 1.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.8 | 3.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.8 | 2.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.8 | 2.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.8 | 2.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.8 | 3.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 38.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 2.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.7 | 6.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 1.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.7 | 115.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.7 | 29.2 | GO:0030016 | myofibril(GO:0030016) |
0.7 | 17.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 2.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.7 | 2.6 | GO:1990696 | USH2 complex(GO:1990696) |
0.6 | 1.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.6 | 5.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 3.1 | GO:0071437 | invadopodium(GO:0071437) |
0.6 | 12.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 7.9 | GO:0005605 | basal lamina(GO:0005605) |
0.6 | 0.6 | GO:0097513 | myosin II filament(GO:0097513) |
0.6 | 1.7 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 1.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.5 | 1.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 3.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.5 | 59.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.5 | 3.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 6.7 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.5 | 1.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 11.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 7.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 3.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 1.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.5 | 14.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.5 | 5.3 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.5 | 1.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.5 | 11.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.5 | 1.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 6.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 1.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.5 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 2.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 0.5 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.5 | 4.1 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 8.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 0.9 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 4.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 3.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 3.4 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.4 | 17.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.4 | 4.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 0.4 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.4 | 0.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 4.2 | GO:0043679 | axon terminus(GO:0043679) |
0.4 | 10.2 | GO:0032420 | stereocilium(GO:0032420) |
0.4 | 8.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 0.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 9.2 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 1.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 3.3 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 1.3 | GO:0097433 | dense body(GO:0097433) |
0.3 | 0.6 | GO:0070160 | occluding junction(GO:0070160) |
0.3 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 1.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 6.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 1.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 71.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 33.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 0.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 15.7 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 1.0 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 1.7 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.2 | GO:0034705 | potassium channel complex(GO:0034705) |
0.2 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 7.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 0.9 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 3.0 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 1.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.6 | GO:0043292 | contractile fiber(GO:0043292) |
0.2 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.0 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 3.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 1.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 2.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 1.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 6.6 | GO:0031256 | leading edge membrane(GO:0031256) |
0.2 | 0.7 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 2.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 4.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 8.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 3.1 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 2.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 7.4 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 9.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 8.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 1.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 1.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 25.0 | GO:0045202 | synapse(GO:0045202) |
0.1 | 2.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 4.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 3.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 2.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 4.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 6.4 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 0.7 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 1.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 8.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 2.9 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.8 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 1.8 | GO:0043005 | neuron projection(GO:0043005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
3.2 | 6.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
3.0 | 9.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.9 | 14.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.8 | 8.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.7 | 10.9 | GO:0031433 | telethonin binding(GO:0031433) |
2.7 | 8.0 | GO:0030172 | troponin C binding(GO:0030172) |
2.5 | 10.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.3 | 7.0 | GO:0051373 | FATZ binding(GO:0051373) |
2.3 | 4.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.3 | 15.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
2.2 | 13.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
2.2 | 8.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.1 | 6.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
2.1 | 2.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
2.0 | 4.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
2.0 | 2.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.9 | 5.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.9 | 5.7 | GO:0035939 | microsatellite binding(GO:0035939) |
1.8 | 5.4 | GO:0070538 | oleic acid binding(GO:0070538) |
1.8 | 5.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.7 | 8.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.7 | 5.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.7 | 3.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.7 | 8.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.6 | 4.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.6 | 8.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.6 | 11.1 | GO:0031432 | titin binding(GO:0031432) |
1.6 | 7.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.6 | 6.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.5 | 3.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.5 | 4.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.5 | 10.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.5 | 4.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.5 | 13.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.5 | 7.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.5 | 4.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.4 | 4.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.4 | 5.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.4 | 2.7 | GO:0031013 | troponin I binding(GO:0031013) |
1.3 | 2.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.3 | 4.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.3 | 6.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.3 | 6.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.3 | 4.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.3 | 5.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.3 | 9.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.3 | 3.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.3 | 6.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.3 | 16.3 | GO:0031402 | sodium ion binding(GO:0031402) |
1.2 | 6.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.2 | 3.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.2 | 3.6 | GO:0071253 | connexin binding(GO:0071253) |
1.2 | 10.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.2 | 6.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.2 | 10.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.2 | 3.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.2 | 22.6 | GO:0003785 | actin monomer binding(GO:0003785) |
1.2 | 1.2 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.1 | 3.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.1 | 2.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.1 | 3.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.1 | 4.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.1 | 24.0 | GO:0052715 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.1 | 3.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.1 | 1.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
1.0 | 4.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.0 | 4.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.0 | 3.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.0 | 6.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 3.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.0 | 3.0 | GO:0055100 | adiponectin binding(GO:0055100) |
1.0 | 18.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.0 | 4.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.0 | 1.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.0 | 7.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.0 | 3.8 | GO:0034711 | inhibin binding(GO:0034711) |
1.0 | 8.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.0 | 4.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.0 | 3.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.9 | 1.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.9 | 3.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.9 | 5.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.9 | 2.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.9 | 4.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.9 | 3.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.9 | 1.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.9 | 15.7 | GO:0005112 | Notch binding(GO:0005112) |
0.9 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.9 | 3.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.9 | 5.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.9 | 2.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.9 | 1.7 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.8 | 5.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.8 | 4.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.8 | 6.6 | GO:0048185 | activin binding(GO:0048185) |
0.8 | 9.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.8 | 22.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.8 | 2.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.8 | 8.9 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.8 | 8.8 | GO:0031005 | filamin binding(GO:0031005) |
0.8 | 4.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.8 | 3.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.8 | 0.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.8 | 7.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 2.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.8 | 3.1 | GO:0043426 | MRF binding(GO:0043426) |
0.8 | 3.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.8 | 1.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.8 | 3.9 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.8 | 6.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.8 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 3.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.7 | 5.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.7 | 6.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 0.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.7 | 2.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.7 | 2.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.7 | 5.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.7 | 18.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.7 | 2.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.7 | 5.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 1.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.7 | 3.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.7 | 3.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.7 | 1.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.7 | 2.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.7 | 3.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 6.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 1.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.7 | 12.1 | GO:0042805 | actinin binding(GO:0042805) |
0.7 | 1.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.7 | 1.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 0.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.7 | 6.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.7 | 7.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.7 | 2.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.6 | 15.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.6 | 3.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.6 | 7.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.6 | 7.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.6 | 4.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 2.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.6 | 1.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 1.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 3.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 18.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 5.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 1.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 6.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.6 | 1.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.6 | 5.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 2.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 18.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.6 | 6.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 14.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 2.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.6 | 5.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.5 | 1.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.5 | 9.2 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.5 | 4.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.5 | 1.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 4.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.5 | 1.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 3.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 12.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 1.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 0.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 12.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.5 | 1.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.5 | 1.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 2.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 7.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.5 | 1.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.5 | 7.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 1.9 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 13.8 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.5 | 1.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 2.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.5 | 11.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.5 | 1.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 2.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.5 | 2.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.5 | 0.5 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.5 | 6.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.5 | 7.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 1.8 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.5 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.5 | 4.1 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.5 | 2.3 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.4 | 2.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 5.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.4 | 6.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.4 | 12.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 1.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 1.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.4 | 0.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.4 | 2.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 26.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 2.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 4.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 2.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 3.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 4.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 1.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 1.5 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 1.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 1.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 0.4 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.4 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 11.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 3.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.4 | 1.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.4 | 1.8 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 1.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 1.4 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 2.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 0.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 1.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 4.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 1.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 1.1 | GO:0034803 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.4 | 2.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 0.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.4 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.3 | 2.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 0.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 2.4 | GO:0018657 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 2.0 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 2.0 | GO:0099528 | G-protein coupled acetylcholine receptor activity(GO:0016907) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.3 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 1.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 2.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 2.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 1.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.3 | 1.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 2.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 1.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 1.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 1.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 1.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 6.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 9.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.3 | 4.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 12.5 | GO:0017022 | myosin binding(GO:0017022) |
0.3 | 4.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 0.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 7.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 2.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 0.9 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 2.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 10.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 4.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 3.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 6.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.3 | 0.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 1.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 2.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 2.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 2.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 2.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 2.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 3.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 65.5 | GO:0003779 | actin binding(GO:0003779) |
0.3 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 1.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 0.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 5.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.5 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.2 | 1.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 8.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 0.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.7 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 3.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 4.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 2.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.2 | 0.9 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 2.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 3.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 2.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 6.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 1.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.2 | 0.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 0.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 3.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 6.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 1.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 2.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 0.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 0.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 1.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 8.1 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.2 | 0.6 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 8.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 1.7 | GO:0052688 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 0.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 2.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 10.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 1.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.9 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 2.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 1.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.7 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 0.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 3.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 2.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 2.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 1.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 4.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 1.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.5 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 1.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 1.0 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 2.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 7.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.4 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 2.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 11.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 2.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 1.1 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 5.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 3.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 36.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.5 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 1.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 15.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.4 | GO:0016631 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 4.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.1 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.1 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 1.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.7 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 1.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 1.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 2.1 | GO:0052757 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) O antigen polymerase activity(GO:0008755) lipopolysaccharide-1,6-galactosyltransferase activity(GO:0008921) cellulose synthase activity(GO:0016759) 9-phenanthrol UDP-glucuronosyltransferase activity(GO:0018715) 1-phenanthrol glycosyltransferase activity(GO:0018716) 9-phenanthrol glycosyltransferase activity(GO:0018717) 1,2-dihydroxy-phenanthrene glycosyltransferase activity(GO:0018718) phenanthrol glycosyltransferase activity(GO:0019112) alpha-1,2-galactosyltransferase activity(GO:0031278) dolichyl pyrophosphate Man7GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0033556) endogalactosaminidase activity(GO:0033931) lipopolysaccharide-1,5-galactosyltransferase activity(GO:0035496) dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042283) inositol phosphoceramide synthase activity(GO:0045140) alpha-(1->3)-fucosyltransferase activity(GO:0046920) indole-3-butyrate beta-glucosyltransferase activity(GO:0052638) salicylic acid glucosyltransferase (ester-forming) activity(GO:0052639) salicylic acid glucosyltransferase (glucoside-forming) activity(GO:0052640) benzoic acid glucosyltransferase activity(GO:0052641) chondroitin hydrolase activity(GO:0052757) dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity(GO:0052824) cytokinin 9-beta-glucosyltransferase activity(GO:0080062) |
0.1 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 9.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.3 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.2 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 1.5 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 10.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.0 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.9 | 12.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 31.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.8 | 3.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 10.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.7 | 1.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.7 | 9.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.7 | 2.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 17.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.6 | 1.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 17.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.6 | 14.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.6 | 18.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.5 | 9.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 3.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.5 | 5.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 15.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.5 | 2.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 17.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 15.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 12.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 4.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 7.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 10.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 3.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 1.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 5.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 15.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 10.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 3.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 7.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 9.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.4 | 9.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 6.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.4 | 4.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 3.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 2.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 20.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 3.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 9.0 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 2.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 12.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 1.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 47.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.3 | 8.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 0.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 8.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 6.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 4.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 4.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 35.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 8.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 2.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 4.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 2.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 1.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 51.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 2.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 52.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.5 | 17.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.3 | 18.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.3 | 18.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.3 | 29.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.1 | 2.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.1 | 20.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.0 | 12.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.0 | 16.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.0 | 1.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.9 | 37.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.9 | 6.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.8 | 9.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.8 | 15.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 9.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.8 | 9.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.7 | 11.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.7 | 13.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 14.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.7 | 5.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.7 | 26.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.7 | 5.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.7 | 21.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.7 | 7.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.7 | 7.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 5.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.7 | 9.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.6 | 14.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 2.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 13.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 9.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.6 | 1.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.6 | 6.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.6 | 5.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 7.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 41.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.6 | 1.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 2.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.6 | 2.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.6 | 1.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 6.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 1.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 5.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 3.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.5 | 2.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 4.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.5 | 5.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 4.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 15.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 5.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 3.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 8.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 0.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.4 | 3.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 3.2 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 0.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.4 | 26.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 5.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 0.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.4 | 3.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 0.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 1.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 12.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 3.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 1.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 1.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 2.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 2.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 4.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 3.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 2.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 3.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 2.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 45.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 2.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 1.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 2.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 2.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 1.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 2.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 1.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 0.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 1.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 2.5 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 2.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 0.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 2.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 0.4 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.2 | 2.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 3.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 1.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 0.2 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.2 | 2.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 0.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 5.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 3.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 3.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 3.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 1.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.1 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 1.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 1.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |